Healthspan Capital
Venture capitalOxford · Seed–Series A · 1 people tracked
Investment thesis
Healthspan Capital invests in a diversified portfolio of early-stage longevity biotechnology companies developing novel approaches to address aging, disease, and human lifespan. The fund leverages deep expertise in longevity biotech company creation and investment, backed by an extensive network of collaborators, advisors, and founders in the space. The rolling fund structure provides simple and flexible access for investors to participate in the longevity biotech sector.
Source: firm website, verified Aug 6, 2026.
Team · 1 people
from public directoriesFrequently asked questions
- What stage does Healthspan Capital invest at?
- Healthspan Capital invests at the Seed, Series A stages.
- What is Healthspan Capital's typical check size?
- Healthspan Capital typically writes checks of $5K.
- What sectors does Healthspan Capital focus on?
- Healthspan Capital focuses on Biotech, Longevity.
- Where is Healthspan Capital located?
- Healthspan Capital is headquartered in Oxford, GB.
Media · Podcasts & interviews
featuring the teamSebastian Brunemeier, Partner at HealthSpan Capital talks to IBTV at Advanced Therapies Europe 2024
IBTV · Sebastian Brunemeier
Similar investors
Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.



